Vieta E, Sánchez-Moreno J, Lahuerta J, Zaragoza S
Bipolar Disorder Programme, Institut Clínic de Neurociencies, Hospital Clinic, Universitat de Barcelona, IDIBAPS, REM-TAP, Barcelona, Spain.
J Affect Disord. 2008 Apr;107(1-3):169-74. doi: 10.1016/j.jad.2007.08.007. Epub 2007 Sep 17.
Subsyndromal depressive symptoms seem to be quite prevalent in mood disorders although very few studies have assessed them in patients considered to be in remission by clinical and psychometric criteria. This study sought to evaluate the presence of subsyndromal depressive symptoms in bipolar and unipolar patients in clinical remission.
One-hundred seventy-six patients with DSM-IV bipolar (62 bipolar I, 58 bipolar II) or unipolar mayor depression (n=58) in clinical remission and 60 healthy subjects were assessed using several psychometric instruments including the 17 items Hamilton Depression Rating Scale (HDRS). To be considered in clinical remission patients assessed with the Clinical Impression for Bipolar Disorder-Modified (CGI-BP-M) had to be stable for 6 months and scoring 6 or less in the Young Mania Rating Scale (YMRS) and 8 or less in the HDRS.
Both Unipolar Disorder (UD) and Bipolar Disorder (BD) patients in clinical remission presented statistically significant higher HRSD scores, than healthy subjects. The HRSD scores were statistically higher in UD patients under remission than in BD patients. The subsyndromal symptoms more strongly associated with a clinical diagnosis of either UD or BD were Depressed Mood, Somatic Anxiety, Impact on Work and Activities, Psychic Anxiety, Gastrointestinal and Somatic Symptoms, Retardation during the Interview and Genital Symptoms.
Subsyndromal depressive symptoms are present in affective disorder patients, both UD and BD, who apparently are in clinical remission. Remitted unipolar patients may have more residual symptoms than bipolar patients, particularly in items related to anxiety and somatic complaints.
亚综合征性抑郁症状在情绪障碍中似乎相当普遍,尽管很少有研究在根据临床和心理测量标准被认为处于缓解期的患者中对其进行评估。本研究旨在评估双相情感障碍和单相情感障碍临床缓解期患者中亚综合征性抑郁症状的存在情况。
使用包括17项汉密尔顿抑郁量表(HDRS)在内的多种心理测量工具,对176例临床缓解期的DSM-IV双相情感障碍(62例双相I型,58例双相II型)或单相重度抑郁症(n = 58)患者以及60名健康受试者进行评估。根据双相情感障碍临床印象修正版(CGI-BP-M)评估被认为处于临床缓解期的患者,必须稳定6个月,且杨氏躁狂量表(YMRS)得分≤6分,HDRS得分≤8分。
临床缓解期的单相情感障碍(UD)和双相情感障碍(BD)患者的HRSD得分在统计学上均显著高于健康受试者。缓解期的UD患者HRSD得分在统计学上高于BD患者。与UD或BD临床诊断更密切相关的亚综合征症状为情绪低落、躯体焦虑、对工作和活动的影响、精神焦虑、胃肠道和躯体症状、访谈时的迟缓及生殖器症状。
亚综合征性抑郁症状存在于明显处于临床缓解期的情感障碍患者中,包括UD和BD患者。缓解期的单相情感障碍患者可能比双相情感障碍患者有更多残留症状,尤其是在与焦虑和躯体主诉相关的项目上。